Article and Vaccines - Pharmacist Digest

STAT+: U.K. lawmaker wants regulators to probe pharma companies over ‘misleading’ Covid-19 vaccines statements

STAT

FEBRUARY 14, 2025

Parliament is calling for regulators to audit pharmaceutical companies that have made misleading statements to the public about their Covid-19 vaccines. A member of the U.K. And the move comes after Moderna was chastised for the second time in five months by a U.K.

Vaccines

Vaccines Communication Pharmaceutical Companies Pharmaceutical Companies

As its cancer vaccine moves through the clinic, Transgene sets sights on manufacturing

PharmaVoice

JULY 9, 2025

Published July 9, 2025 Amy Baxter Staff Reporter post share post print email license Stock via Getty Images Listen to the article 6 min This audio is auto-generated. Cancer vaccine efficacy Transgene is taking aim at early-stage cancers with virus-based therapies targeting neoantigens on tumors.

Vaccines

Vaccines Immunity Immunization Drug Development

Implications of RFK Jr.’s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry

PharmaTech

JUNE 10, 2025

s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. Kennedy Jr. Industry groups have also raised serious concerns.

Vaccines

Vaccines Insurance Coverage and Processing Dosage Drug Development

Flu Vaccines Are a Go

Pharmacy Times

JULY 16, 2025

The shift away from thimerosal may increase the use of single-dose syringes, impacting vaccination practices in various healthcare settings. ACIP's recommendations are increasingly significant for pharmacies, influencing vaccination planning, billing, and patient care activities.

Vaccines

Vaccines Insurance Coverage and Processing Pharmacy Technician Community Pharmacies

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Pharmacy Times

JUNE 20, 2025

Expanding use of the 15-valent pneumococcal conjugate vaccine (PCV15) or 20-valent pneumococcal conjugate vaccine (PCV20) to all United States adults aged 50 to 64 years would result in modest budget increases over a 3-year period. 1,2 A particular disease burden is present for Black Americans.

Vaccines

Vaccines Pharmacy Technician Immunity Immunization

Insights From ASCO 2025 Guide Pharmacy Practice in Solid Tumors and Hematologic Cancers

Pharmacy Times

JULY 16, 2025

ASCO 2025: insights on NALIRIFOX use in metastatic pancreatic ductal adenocarcinoma from the NAPOLI-3 trial. Pharmacy Times. June 5, 2025. Accessed June 23, 2025.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Pharmacy Technician Diabetes Compounding Pharmacies

Addressing US FDA challenges in Indian sterile drug manufacturing – Part 1

Express Pharma

JUNE 19, 2025

Indian pharmaceutical companies supply more than 60 per cent of global demand for vaccines and over 40 per cent of generic medicines consumed in the United States (2). This growth is further driven by global shortages of sterile products, an expanding biologics pipeline, and the demand for emergency-use therapies including vaccines.

Documentation

Documentation Vaccines Pharmaceutical Companies Pharmaceutical Companies

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Pharmacy Times

JUNE 27, 2025

Pharmacists are well positioned to perform drug interaction checks, counsel patients on adherence and administration, and coordinate supportive care, including prophylaxis for infections (eg, granulocyte colony-stimulating factor, vaccines). Acalabrutinib plus bendamustine and rituximab may become new standard care for untreated MCL.

STAT+: U.K. lawmaker wants regulators to probe pharma companies over ‘misleading’ Covid-19 vaccines statements

As its cancer vaccine moves through the clinic, Transgene sets sights on manufacturing

Trending Sources

Implications of RFK Jr.’s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry

Flu Vaccines Are a Go

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Insights From ASCO 2025 Guide Pharmacy Practice in Solid Tumors and Hematologic Cancers

Addressing US FDA challenges in Indian sterile drug manufacturing – Part 1

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

You Shall Not Pass: Pharmacist Review of Drug-Herb Interactions in Cancer Treatment

Pharmacies Need Strategies to Improve Health Care Access

Transitions of Care Pharmacists Mitigate Readmission Rates for COPD

Pharmacists Push Forward: Innovative Clinical Solutions Highlighted at McKesson ideaShare 2025

Study Reveals Gaps in GINA Guideline Adherence for Asthma Treatment

Beyond Dispensing: How Pharmacists and Technicians Can Expand Services to Meet Patient Needs

USP announces new Advanced Technologies Laboratory to accelerate and scale pharmaceutical manufacturing innovations

Nemolizumab Shows Rapid, Sustained Efficacy in Atopic Dermatitis

Continuous Subcutaneous Lenalidomide Shows Promise in Reducing Toxicity in R/R Multiple Myeloma

Pharmacists Can Provide Travel Health Tips for Patients

Effective Control of Microorganisms in Pharmaceutical Manufacturing

IsaKRD Induction Achieves 95% Response Rate in Multiple Myeloma

FDA Approves Dupilumb for Treatment of Bullous Pemphigoid

Secondary Analysis Investigates Spillover Effects of Antibiotic Audit and Feedback

3 of the year’s most notable FDA nods

FDA Removes REMS for Currently Approved BCMA-, CD19-Directed CAR T Cell Immunotherapies

Evaluation of a Pharmacy-Delivered Oncofertility Intervention

The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

Zimislecel Could Pave the Way for a Type 1 Diabetes Cure

FDA Approves First, Only Single-Pill Triple Combination for Treatment of Hypertension

Real-World Data Shows Similar Clinical Outcomes in Patients Receiving Biosimilars Following Switch From Reference Product

Daily CBD Use at Consumer-Level Doses May Elevate Liver Enzymes, FDA-Led Trial Shows

Correct Patient Misconceptions Around Biosimilars

Zanubrutinib Outperforms Acalabrutinib in Adjusted Head-to-Head Analysis

Understanding Biologics and Biosimilars Amid an Evolving Treatment Landscape

Lumateperone Submits Application for Schizophrenia Indication to FDA for Supplemental New Drug

Pharmacists Have a Crucial Role Helping Patients With ATTR-CM Navigate Treatment With Tafamidis

Independent Pharmacy Innovation Spotlighted at McKesson ideaShare 2025

Large Real-World Study Validates Idecabtagene Vicleucel Outcomes Seen in KarMMa Trial

FDA Approves Vancomycin Injection For Ready-to-Infuse Sepsis Therapy

Zanubrutinib Linked to Lower Infection Risk Than Venetoclax Plus Obinutuzumab in Real-World CLL/SLL Study

FDA Approves Dupilumab for Treatment of Bullous Pemphigoid

FDA Approves Y-90 Resin Microspheres for Unrespectable Hepatocellular Carcinoma

ADA 2025: Oral Semaglutide Demonstrates Cardiovascular Benefits in SOUL Trial

Does Corticosteroid Use Have a Role in Severe Community-Acquired Pneumonia?

Stay Connected